Summary
- The Kerala High Court has addressed the issue of costly patented drugs under Section 100 of the Patents Act.
- The court emphasized that the government's power to use patents can be invoked in the interest of public health.
- This ruling could significantly impact access to essential medications for patients in need.
- Legal experts are closely watching how this decision may influence future patent regulations and drug pricing in India.
Join the discussion — sign up to comment, upvote, and save articles.